RCSA
BSX icon

REYL & Cie S.A.’s Boston Scientific BSX Stock Holding History

REYL & Cie S.A.’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$47.3K Buy
+752
New +$40.8K 0.05% 114

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

REYL & Cie S.A.'s BSX Position: Q2 2026 in Review

REYL & Cie S.A. opened a new position in Boston Scientific (BSX) in Q2 2026: 752 shares worth $47.3K. The stake represents 0.05% of the portfolio and ranks #114 among its holdings.

1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • REYL & Cie S.A. held 752 shares of Boston Scientific worth $47.3K as of Q2 2026.
  • Boston Scientific was a new REYL & Cie S.A. position in Q2 2026.
  • Boston Scientific made up 0.05% of REYL & Cie S.A.'s portfolio in Q2 2026, its #114 holding.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on REYL & Cie S.A.'s 13F filing for Q2 2026, filed 2 Oct 2026.